Braeden Lichti's most recent trade in Elevai Labs Inc. was a trade of 3,336,437 Series B Preferred Stock done . Disclosure was reported to the exchange on March 26, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Elevai Labs Inc. | Braeden Lichti | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2025 | 3,336,437 | 3,336,437 | - | 0 | Series B Preferred Stock |